Go to deals
Healthcare

Heaven Sent Naturals, affiliates have been acquired by Wellgenix LLC/Red Oak Capital PE

The private shareholders of Heaven Sent Naturals, Puri-Clean and Covert Labs have sold a 51.5% stake in the companies, to Red Oak Capital, a Texas-based investment company that has made a wide range of investments and focuses on profitable companies, for US$25.54 million.

Heaven Sent Naturals, Puri-Clean and Covert Labs are three related companies in the nutritional supplement industry. Their products are sold in numerous independent and health food chain stores across the USA. The shareholders had built the company from a start-up to its present size over a 15-year period and recognized the need for additional expertise to take the company through the next growth stage.

Oaklins' team in Dallas advised the seller in this transaction, which was structured to deliver cash proceeds of 66% at closing and the remaining 33% to be paid annually over the next 5 years.

Parties

Talk to the deal team

Bryan Livingston

Managing Partner
Dallas, United States
Oaklins Capital Alliance

Related deals

Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Healthcare

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Learn more
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more